Squarepoint’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.73M | Sell |
18,370
-40,505
| -69% | -$18.7M | 0.01% | 1124 |
|
|
2026
Q1 | $28.3M | Buy |
58,875
+25,406
| +76% | +$13M | 0.03% | 538 |
|
|
2025
Q4 | $18.8M | Buy |
33,469
+22,930
| +218% | +$13M | 0.02% | 766 |
|
|
2025
Q3 | $5.42M | Sell |
10,539
-26,670
| -72% | -$11.6M | 0.01% | 1414 |
|
|
2025
Q2 | $11.7M | Sell |
37,209
-10,396
| -22% | -$3.12M | 0.01% | 995 |
|
|
2025
Q1 | $14.5M | Buy |
47,605
+17,184
| +56% | +$5.78M | 0.02% | 844 |
|
|
2024
Q4 | $10.1M | Sell |
30,421
-8,703
| -22% | -$2.95M | 0.01% | 1143 |
|
|
2024
Q3 | $13.1M | Buy |
39,124
+22,861
| +141% | +$8.68M | 0.02% | 815 |
|
|
2024
Q2 | $6.7M | Sell |
16,263
-8,637
| -35% | -$3.42M | 0.01% | 1174 |
|
|
2024
Q1 | $10.1M | Buy |
24,900
+4,087
| +20% | +$1.44M | 0.02% | 996 |
|
|
2023
Q4 | $6.38M | Sell |
20,813
-41,652
| -67% | -$11.2M | 0.01% | 1238 |
|
|
2023
Q3 | $15.1M | Sell |
62,465
-45,364
| -42% | -$11.6M | 0.04% | 583 |
|
|
2023
Q2 | $25.9M | Sell |
107,829
-22,496
| -17% | -$4.67M | 0.08% | 288 |
|
|
2023
Q1 | $24.5M | Buy |
130,325
+63,730
| +96% | +$13.2M | 0.1% | 220 |
|
|
2022
Q4 | $14.1M | Buy |
66,595
+35,668
| +115% | +$7.13M | 0.06% | 368 |
|
|
2022
Q3 | $4.86M | Buy |
+30,927
| New | +$4.94M | 0.02% | 780 |
|
|
2022
Q2 | – | Sell |
-4,039
| Closed | -$661K | – | 3179 |
|
|
2022
Q1 | $661K | Sell |
4,039
-7,680
| -66% | -$1.27M | ﹤0.01% | 1845 |
|
|
2021
Q4 | $2.55M | Buy |
+11,719
| New | +$2.45M | 0.01% | 1114 |
|
|
2021
Q1 | – | Sell |
-18,619
| Closed | -$2.59M | – | 3417 |
|
|
2020
Q4 | $2.59M | Buy |
18,619
+5,984
| +47% | +$754K | 0.02% | 806 |
|
|
2020
Q3 | $1.41M | Sell |
12,635
-931
| -7% | -$108K | 0.02% | 813 |
|
|
2020
Q2 | $1.26M | Buy |
13,566
+10,330
| +319% | +$879K | 0.02% | 822 |
|
|
2020
Q1 | $237K | Sell |
3,236
-34,385
| -91% | -$2.99M | 0.01% | 1402 |
|
|
2019
Q4 | $3.16M | Sell |
37,621
-67,862
| -64% | -$5.25M | 0.02% | 661 |
|
|
2019
Q3 | $8.87M | Buy |
105,483
+67,964
| +181% | +$5.14M | 0.08% | 315 |
|
|
2019
Q2 | $2.45M | Sell |
37,519
-38,532
| -51% | -$2.22M | 0.02% | 731 |
|
|
2019
Q1 | $4.49M | Buy |
76,051
+16,372
| +27% | +$978K | 0.05% | 479 |
|
|
2018
Q4 | $3.16M | Sell |
59,679
-1,821
| -3% | -$100K | 0.04% | 536 |
|
|
2018
Q3 | $3.68M | Buy |
61,500
+38,983
| +173% | +$2.13M | 0.04% | 492 |
|
|
2018
Q2 | $968K | Buy |
+22,517
| New | +$910K | 0.01% | 906 |
|
|
2018
Q1 | – | Sell |
-8,169
| Closed | -$296K | – | 1951 |
|
|
2017
Q4 | $296K | Buy |
+8,169
| New | +$286K | 0.01% | 1524 |
|
|
2017
Q1 | – | Sell |
-6,300
| Closed | -$227K | – | 1748 |
|
|
2016
Q4 | $227K | Buy |
+6,300
| New | +$210K | 0.01% | 1345 |
|
Other funds holding MEDP
WA
Squarepoint's MEDP Position: Q2 2026 in Review
Squarepoint reduced its Medpace (MEDP) stake by 69% in Q2 2026, selling an estimated $18.7M and leaving 18,370 shares worth $9.73M. The position accounts for 0.01% of the portfolio, ranked #1124.
Squarepoint first reported a position in MEDP in Q4 2016 and has held it in 31 quarters since. The position peaked at $28.3M in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Squarepoint held 18,370 shares of Medpace worth $9.73M as of Q2 2026.
- Squarepoint sold 40,505 Medpace shares in Q2 2026, an estimated $18.7M.
- Medpace made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1124 holding.
- Squarepoint first reported a position in Medpace in Q4 2016 and has held it in 31 quarters since.
- Squarepoint's Medpace position peaked at $28.3M in Q1 2026.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.